Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

POM

Pomdoctor Ltd ADR

May 28 • 12:27PM ET

0.1002

-0.0154 -13.32 %

Healthcare • Pharmaceutical Retailers • China • Nano • NASD

Today, 8:05 AMPomdoctor to implement 1-for-18 reverse ADS split around June 22, 2026

Peers: PETS HITI LFMD MD EVH VRA BBW SBH FLWS BTBT

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	126.84M	Perf Week	-19.65%
Market Cap	12.71M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-76.12%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	0.67%	Short Float	-	Perf Quarter	-57.36%
Income	-	P/S	-	EPS this Y	-	Inst Trans	1.61%	Short Ratio	0.16	Perf Half Y	-97.82%
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	1.22M	Perf YTD	-66.02%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	6.43 -98.44%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	-47.89% -10.17%	ROIC	-	52W Low	0.06 54.39%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	15.17% 22.15%	Gross Margin	-	Volatility	15.37% 67.92%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	35.91	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-52.53%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-64.65%	Rel Volume	0.39	Prev Close	0.12
Employees	165	LT Debt/Eq	-	Earnings	May 14 AMC	SMA200	-93.38%	Avg Volume	7.51M	Price	0.10
IPO	Oct 08, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,397,662	Change	-13.32%

Today 08:00AM	POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change (PR Newswire) -13.32%
May-14-26 04:30PM	POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results (PR Newswire) -8.51%
Mar-13-26 08:00AM	POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management (PR Newswire)
Feb-11-26 12:15PM	Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately (PR Newswire)
Feb-04-26 08:00AM	POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities (PR Newswire)
06:00AM	Loading…
Feb-02-26 06:00AM	POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice (PR Newswire) +5.15%
Jan-16-26 09:00AM	POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies (PR Newswire)
Dec-03-25 04:15PM	POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results (PR Newswire) +5.36%
Oct-10-25 05:15PM	POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option (PR Newswire) -8.81%
02:57PM	Should You Buy POM Stock After the PomDoctor IPO? (Barchart)
Oct-09-25 04:05PM	POMDOCTOR LIMITED Announces Closing of Initial Public Offering (PR Newswire) +18.36%
Oct-08-25 08:00AM	POMDOCTOR LIMITED Announces Pricing of Initial Public Offering (PR Newswire)

PomDoctor Ltd. operates as an online medical services platform, which specializes in chronic disease management and pharmaceutical services. It operates through two segments: Internet hospital and pharmaceutical supply chain. The Internet hospital segment include online consultation and prescription renewal and CDM service. The pharmaceutical supply chain provides other pharmaceutical platforms with supply chain management and platform operation services. The company was founded by Zhenyang Shi and Li Xu on February 01, 2021 and is headquartered in Guangzhou, China.

Co-FounderMr. Zhenyang Shi

Co-Founder & CFOMs. Li Xu

VP & DirectorMr. Guoji Luo

Vice PresidentMr. Dexiang Wei

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

POM

Pomdoctor Ltd ADR

Upgrade your Finviz experience